162 related articles for article (PubMed ID: 4016746)
1. Monoclonal antibodies against a component related to soluble estrogen receptor.
Coffer AI; Lewis KM; Brockas AJ; King RJ
Cancer Res; 1985 Aug; 45(8):3686-93. PubMed ID: 4016746
[TBL] [Abstract][Full Text] [Related]
2. Immunoradiometric studies with monoclonal antibody against a component related to human estrogen receptor.
Coffer AI; Spiller GH; Lewis KM; King RJ
Cancer Res; 1985 Aug; 45(8):3694-8. PubMed ID: 4016747
[TBL] [Abstract][Full Text] [Related]
3. Immunocytochemical localization of progesterone receptors in breast cancer with anti-human receptor monoclonal antibodies.
Elashry-Stowers D; Zava DT; Speers WC; Edwards DP
Cancer Res; 1988 Nov; 48(22):6462-74. PubMed ID: 3180062
[TBL] [Abstract][Full Text] [Related]
4. Cross-reactivity of a monoclonal antibody directed against an estrogen-induced protein in MCF-7 human breast cancer cells with murine Leydig cell tumor proteins.
Melner MH; Voigt W; Puett D
Cancer Res; 1986 Jan; 46(1):328-31. PubMed ID: 3940199
[TBL] [Abstract][Full Text] [Related]
5. Histochemical studies with a monoclonal antibody raised against a partially purified soluble estradiol receptor preparation from human myometrium.
King RJ; Coffer AI; Gilbert J; Lewis K; Nash R; Millis R; Raju S; Taylor RW
Cancer Res; 1985 Nov; 45(11 Pt 2):5728-33. PubMed ID: 2413995
[TBL] [Abstract][Full Text] [Related]
6. Steroid receptor forms and their interaction with cytoplasmic modulators.
Sato B; Nishizawa Y; Maeda Y; Noma K; Honma T; Matsumoto K
J Steroid Biochem; 1983 Jul; 19(1A):315-21. PubMed ID: 6887866
[TBL] [Abstract][Full Text] [Related]
7. Interactions between precipitating and nonprecipitating antibodies in the formation of immune complexes.
Cosio FG; Birmingham DJ; Sexton DJ; Hebert LA
J Immunol; 1987 Apr; 138(8):2587-92. PubMed ID: 3559208
[TBL] [Abstract][Full Text] [Related]
8. Binding and endocytosis of a monoclonal antibody to a high molecular weight human milk fat globule membrane-associated antigen by cultured MCF-7 breast carcinoma cells.
Aboud-Pirak E; Sergent T; Otte-Slachmuylder C; Abarca J; Trouet A; Schneider YJ
Cancer Res; 1988 Jun; 48(11):3188-96. PubMed ID: 3365702
[TBL] [Abstract][Full Text] [Related]
9. Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells.
Miller MA; Lippman ME; Katzenellenbogen BS
Cancer Res; 1984 Nov; 44(11):5038-45. PubMed ID: 6488162
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibodies to human lung tumor antigens demonstrated by immunofluorescence and immunoprecipitation.
Brenner BG; Jothy S; Shuster J; Fuks A
Cancer Res; 1982 Aug; 42(8):3187-92. PubMed ID: 7046919
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal and polyclonal antibodies to human progesterone receptor peptide-(533-547) recognize a specific site in unactivated (8S) and activated (4S) progesterone receptor and distinguish between intact and proteolyzed receptors.
Traish AM; Wotiz HH
Endocrinology; 1990 Sep; 127(3):1167-75. PubMed ID: 2201532
[TBL] [Abstract][Full Text] [Related]
12. Tissue distribution of an epithelial and tumor-associated antigen recognized by monoclonal antibody F36/22.
Croghan GA; Papsidero LD; Valenzuela LA; Nemoto T; Penetrante R; Chu TM
Cancer Res; 1983 Oct; 43(10):4980-8. PubMed ID: 6349797
[TBL] [Abstract][Full Text] [Related]
13. Antibody-recognized [125I]estradiol-receptor complex in ovarian epithelial carcinoma.
Holt JA; Lorincz MA; King WJ
Obstet Gynecol; 1983 Aug; 62(2):231-5. PubMed ID: 6866366
[TBL] [Abstract][Full Text] [Related]
14. Characterization of a unique nuclear estrogen-binding component in an estrogen-responsive mouse Leydig cell tumor.
Maeda Y; Sato B; Noma K; Kishimoto S; Koizumi K; Aono T; Matsumoto K
Cancer Res; 1983 Sep; 43(9):4091-7. PubMed ID: 6871850
[TBL] [Abstract][Full Text] [Related]
15. Relationship of monoclonal antibody binding to estrogen and progesterone receptor content in breast cancer.
Hendler FJ; Yuan D
Cancer Res; 1985 Jan; 45(1):421-9. PubMed ID: 3965148
[TBL] [Abstract][Full Text] [Related]
16. Detection of antigens recognized by a novel monoclonal antibody in tissue and serum from patients with breast cancer.
Iacobelli S; Arnò E; D'Orazio A; Coletti G
Cancer Res; 1986 Jun; 46(6):3005-10. PubMed ID: 3516389
[TBL] [Abstract][Full Text] [Related]
17. Partial characterization of protease(s) in human breast cancer cytosols that can degrade estrogen and progesterone receptors selectively.
Maeda K; Tsuzimura T; Nomura Y; Sato B; Matsumoto K
Cancer Res; 1984 Mar; 44(3):996-1001. PubMed ID: 6362861
[TBL] [Abstract][Full Text] [Related]
18. [Determination of ER-D5 (estrogen receptor related antigen) in prostatic cancer and its significance].
Ohishi M; Miyake K; Koshikawa T; Asai J; Murase T
Hinyokika Kiyo; 1992 Jul; 38(7):789-96. PubMed ID: 1381866
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies recognizing tumor-associated antigen of human ovarian mucinous cystadenocarcinomas.
Bhattacharya M; Chatterjee SK; Barlow JJ; Fuji H
Cancer Res; 1982 May; 42(5):1650-4. PubMed ID: 6175395
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibodies to human prostate and bladder tumor-associated antigens.
Starling JJ; Sieg SM; Beckett ML; Schellhammer PF; Ladaga LE; Wright GL
Cancer Res; 1982 Aug; 42(8):3084-9. PubMed ID: 7046915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
